TY - JOUR
T1 - Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting
AU - Omar, Rawan
AU - Bardoogo, Yael Leichtman
AU - Corem-Salkmon, Enav
AU - Mizrahi, Boaz
N1 - Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2017/7/10
Y1 - 2017/7/10
N2 - Camptothecin (CPT) is a naturally occurring cytotoxic alkaloid having a broad spectrum of antitumor activity. Unfortunately, it has low bioavailability and encapsulation efficiency, limiting its clinical use. We report on our efforts to develop a novel drug delivery prototype composed of a short, star hydrophilic polyethylene glycol (PEG) backbone and hydrophobic CPT (PEG4-CPT). The amphiphilic bio-conjugate self-assembles in water into stable spherical nano-particles with a mean diameter of 200 nm and CPT substitution percentage of 27%w/w. CPT is released in a sustained release profile without burst effect. In addition, PEG4-CPT nano-particles are able to load a co-drug, water soluble or non-water soluble doxorubicin and release them simultaneously with the free CPT. The biological evaluation of PEG4-CPT against HeLa cells showed improved cellular uptake and enhanced cytotoxicity compared to free CPT. Thus, in this approach CPT acts in two ways: As the hydrophobic segment that enables self-assembly in water and as a potent anticancer agent. This concept of combining hydrophobic drugs and short star polymers shows great potential for efficient delivery of hydrophobic chemotrophic drugs as well as for drugs with inherent stability and pharmacokinetic barriers.
AB - Camptothecin (CPT) is a naturally occurring cytotoxic alkaloid having a broad spectrum of antitumor activity. Unfortunately, it has low bioavailability and encapsulation efficiency, limiting its clinical use. We report on our efforts to develop a novel drug delivery prototype composed of a short, star hydrophilic polyethylene glycol (PEG) backbone and hydrophobic CPT (PEG4-CPT). The amphiphilic bio-conjugate self-assembles in water into stable spherical nano-particles with a mean diameter of 200 nm and CPT substitution percentage of 27%w/w. CPT is released in a sustained release profile without burst effect. In addition, PEG4-CPT nano-particles are able to load a co-drug, water soluble or non-water soluble doxorubicin and release them simultaneously with the free CPT. The biological evaluation of PEG4-CPT against HeLa cells showed improved cellular uptake and enhanced cytotoxicity compared to free CPT. Thus, in this approach CPT acts in two ways: As the hydrophobic segment that enables self-assembly in water and as a potent anticancer agent. This concept of combining hydrophobic drugs and short star polymers shows great potential for efficient delivery of hydrophobic chemotrophic drugs as well as for drugs with inherent stability and pharmacokinetic barriers.
KW - Camptothecin
KW - Cancer
KW - Conjugates
KW - Drug delivery
KW - Self-assembly
UR - http://www.scopus.com/inward/record.url?scp=85000415047&partnerID=8YFLogxK
U2 - 10.1016/j.jconrel.2016.09.025
DO - 10.1016/j.jconrel.2016.09.025
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27677603
AN - SCOPUS:85000415047
SN - 0168-3659
VL - 257
SP - 76
EP - 83
JO - Journal of Controlled Release
JF - Journal of Controlled Release
ER -